PL448126A1 - Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo - Google Patents

Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo

Info

Publication number
PL448126A1
PL448126A1 PL448126A PL44812624A PL448126A1 PL 448126 A1 PL448126 A1 PL 448126A1 PL 448126 A PL448126 A PL 448126A PL 44812624 A PL44812624 A PL 44812624A PL 448126 A1 PL448126 A1 PL 448126A1
Authority
PL
Poland
Prior art keywords
diseased skin
skin care
oil
medical preparation
stearate
Prior art date
Application number
PL448126A
Other languages
English (en)
Inventor
Waldemar Placek
Agnieszka Owczarczyk-Saczonek
Ewa Wygonowska
Ryszard Górecki
Marta Kasprowicz-Furmańczyk
Lesław Bernard Lahuta
Magdalena Ligor
Bogusław BUSZEWSKI
Witold Sujka
Grażyna KASZCZYK
Original Assignee
Uniwersytet Mikołaja Kopernika W Toruniu
Uniwersytet Warmińsko-Mazurski w Olsztynie
Fabryka Kosmetyków Pollena Ewa Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Mikołaja Kopernika W Toruniu, Uniwersytet Warmińsko-Mazurski w Olsztynie, Fabryka Kosmetyków Pollena Ewa Spółka Akcyjna filed Critical Uniwersytet Mikołaja Kopernika W Toruniu
Priority to PL448126A priority Critical patent/PL448126A1/pl
Publication of PL448126A1 publication Critical patent/PL448126A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Przedmiotem zgłoszenia jest preparat leczniczy do pielęgnacji skóry zmienionej chorobowo zawierający w swoim składzie wodę i oleje, który składa się z wody w ilości od 60,0% do 80,00%, D-chiro-inozytolu DCI od 0,5% do 1,5%, stearynianu 2-poliglicerolu od 2,00% do 4,00%, stearynianu glicerolu od 1,00% do 3,00%, alkoholu stearylowego od 0,5% do 1,5%, oleju z lnianki siewnej od 1,00% do 3,00%, oleju konopnego od 4,00% do 8,00%, oleju rzepakowego od 4,00% do 8,00%, izostearynianu izostearylu od 1,00% do 3,00%, izostearynianu izopropylu od 1,00% do 3,00%, eter benzylowego kwasu mirystynowego PPG-3 od 1,00% do 3,00%, trójglicerydu kwasu kaprylowego/kaprynowego od 0,1% do 1,00%, soli sodowej kopolimerów akrylowych (od 0,1% do 1,00%).
PL448126A 2024-03-28 2024-03-28 Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo PL448126A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL448126A PL448126A1 (pl) 2024-03-28 2024-03-28 Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL448126A PL448126A1 (pl) 2024-03-28 2024-03-28 Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo

Publications (1)

Publication Number Publication Date
PL448126A1 true PL448126A1 (pl) 2025-09-29

Family

ID=97171688

Family Applications (1)

Application Number Title Priority Date Filing Date
PL448126A PL448126A1 (pl) 2024-03-28 2024-03-28 Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo

Country Status (1)

Country Link
PL (1) PL448126A1 (pl)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013030459A1 (en) * 2011-09-02 2013-03-07 Clanet Oy Lipid composition for the prevention or treatment of skin problems
PL225026B1 (pl) * 2014-08-04 2017-02-28 Renata Firgon Kompozycja do terapii łuszczycy oraz egzemy
PL437191A1 (pl) * 2021-03-01 2022-09-05 Ester Labs OÜ Formulacja do stosowania zewnętrznego oraz jej zastosowanie

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013030459A1 (en) * 2011-09-02 2013-03-07 Clanet Oy Lipid composition for the prevention or treatment of skin problems
PL225026B1 (pl) * 2014-08-04 2017-02-28 Renata Firgon Kompozycja do terapii łuszczycy oraz egzemy
PL437191A1 (pl) * 2021-03-01 2022-09-05 Ester Labs OÜ Formulacja do stosowania zewnętrznego oraz jej zastosowanie

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OWCZARCZYK-SACZONEK A, CZERWIŃSKA J, WYGONOWSKA E, KASPROWICZ-FURMAŃCZYK M, PLACEK W.: "Dermatol Ther. 2021 Jan;34(1):e14538", D-CHIRO-INOSITOL AS A TREATMENT IN PLAQUE PSORIASIS: A RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL, DOI: 10.1111/dth.14538 *

Similar Documents

Publication Publication Date Title
JP6794420B2 (ja) 外用医薬組成物
Izzo et al. Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors
JP4615671B2 (ja) 炎症存在下使用用のしわ形成又は皮膚の弾力喪失の防止剤
Dahlén et al. Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo
BRPI0408556A (pt) formulações dispersìvel de um agente antiinflamatório
PT643960E (pt) Utilizacao de uma quantidade eficaz de substancias activas para o tratamento das peles mistas
CN111050767A (zh) 预防或治疗睡眠障碍的组合物
RU2313333C2 (ru) Крем для лечения кожи, поврежденной солнцем
NO158922B (no) Fremgangsmaate til fremstilling av azolderivatholdig antimykotisk middel med hoey frigjoering av virksomme stoffer.
Knolle et al. Comparison of cooling and EMLA to reduce the burning pain during capsaicin 8% patch application: a randomized, double-blind, placebo-controlled study
PL448126A1 (pl) Preparat leczniczy do pielęgnacji skóry zmienionej chorobowo
RU2011120054A (ru) Композиции для лечения эпителиальной ткани
Vercruysse et al. Epidemiology of seasonal falciparum malaria in an urban area of Senegal
Ceyhan EFFECT OF ESTRUS SYNCHRONIZATION PROTOCOLS INCLUDING PGF 2 α AND GnRH ON FERTILITY PARAMETERS IN HAIR GOATS DURING BREEDING SEASON
JP6542006B2 (ja) 外用医薬組成物
Redfern et al. Incremental propofol for short procedures
Dikstein et al. In vivo measurement of some elastic properties of human skin
Heppner et al. Urothelium-derived prostanoids enhance contractility of urinary bladder smooth muscle and stimulate bladder afferent nerve activity in the mouse
CA2490681C (en) Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
IL165755A (en) Composition and solution comprising avian appeasing pheromones and a process to decrease stress, anxiety and aggressiveness
WO2001070187A1 (en) LOW pH HIGH FATTY ACID VANISHING CREAM
JP2014166979A (ja) ロキソプロフェン含有外用固形剤
JP4704419B2 (ja) 皮膚角化促進剤
Kanaar Lipolysis of skin-surface lipids of acne vulgaris patients and healthy controls
JP7706218B2 (ja) 皮脂分泌促進剤